Hepsin promotes prostate cancer progression and metastasis.

[1]  W. Kisiel,et al.  Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation (*) , 1995, The Journal of Biological Chemistry.

[2]  R. Nagle,et al.  Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. , 1995, The American journal of pathology.

[3]  O. Cussenot,et al.  Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. , 1997, European journal of cancer.

[4]  K. Shigemasa,et al.  Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. , 1997, Cancer research.

[5]  M. Halks-Miller,et al.  Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. , 1998, The Journal of clinical investigation.

[6]  R. Matusik,et al.  Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[7]  Analytical molecular pathology of epithelial-stromal interactions in the normal and neoplastic prostate. , 1998, Analytical and quantitative cytology and histology.

[8]  Thiennu H. Vu,et al.  Matrix‐degrading proteases and angiogenesis during development and tumor formation , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[9]  J. Morser,et al.  Corin, a Mosaic Transmembrane Serine Protease Encoded by a Novel cDNA from Human Heart* , 1999, The Journal of Biological Chemistry.

[10]  C. Craik,et al.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Hood,et al.  Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. , 1999, Cancer research.

[12]  W. Carter,et al.  Targeted Disruption of the LAMA3 Gene in Mice Reveals Abnormalities in Survival and Late Stage Differentiation of Epithelial Cells , 1999, The Journal of cell biology.

[13]  E. Fuchs,et al.  The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Gress,et al.  A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. , 2000, Cancer research.

[15]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[16]  R. Matusik,et al.  A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. , 2000, Endocrinology.

[17]  M. Shen,et al.  Molecular genetics of prostate cancer. , 2000, Genes & development.

[18]  J. Clements,et al.  Type II Transmembrane Serine Proteases , 2001, The Journal of Biological Chemistry.

[19]  E. Fuchs,et al.  Hyperproliferation and Defects in Epithelial Polarity upon Conditional Ablation of α-Catenin in Skin , 2001, Cell.

[20]  Jeffrey A. Magee,et al.  Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.

[21]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[22]  R. Nagle,et al.  Unique expression pattern of the α6β4 integrin and laminin‐5 in human prostate carcinoma , 2001 .

[23]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[24]  M. Bittner,et al.  Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.

[25]  T. Stamey,et al.  Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.

[26]  Z. Werb,et al.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. , 2001, Trends in cell biology.

[27]  S. Nakahara,et al.  Prometastatic Effect ofN-Acetylglucosaminyltransferase V Is Due to Modification and Stabilization of Active Matriptase by Adding β1–6 GlcNAc Branching* , 2002, The Journal of Biological Chemistry.

[28]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[29]  V. Srikantan,et al.  HEPSIN inhibits cell growth/invasion in prostate cancer cells. , 2002, Cancer research.

[30]  Matthias Kretzler,et al.  Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.

[31]  A. Moorman,et al.  Non‐radioactive in situ detection of mRNA in ES cell‐derived cardiomyocytes and in the developing heart , 2002, Microscopy research and technique.

[32]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[33]  T. Stamey,et al.  Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. , 2003, The Journal of urology.

[34]  Qingyu Wu.  Type II transmembrane serine proteases. , 2003, Current topics in developmental biology.

[35]  R. Dickson,et al.  Type II transmembrane serine proteases , 2003, Thrombosis and Haemostasis.

[36]  M. Rubin,et al.  Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.

[37]  James P. Quigley,et al.  Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer , 2003, Cancer and Metastasis Reviews.

[38]  S. Loening,et al.  Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. , 2004, The Journal of urology.

[39]  L. Magnelli,et al.  Multiple pathways of cell invasion are regulated by multiple families of serine proteases , 2004, Clinical & Experimental Metastasis.

[40]  V. Robinson,et al.  The basic biology of metastasis. , 2004, Cancer treatment and research.